Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Non-coding RNAs could help detect and treat radiation damage.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Afatinib often causes skin problems that need proactive management.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Different types of skin fibroblasts have unique roles in skin health and disease.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Reflexology massage helps hair regrowth in women after chemotherapy.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The document concludes that modern ocular cosmetics enhance beauty and eyelash health, with safe practices and regulations being important.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Extracellular vesicles show promise for wound healing, but more research is needed to improve their stability and production.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.